Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2015 · third_quarter · 3@
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
Implementation of the Biologics Price Competition and Innovation Act (BPCIA); CMS Proposed Rule {CMS-1631-P} RIN 0938-AS40 - Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016
Source: Senate LDA
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
Safeguarding America's Pharmaceuticals Act of 2013
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR. 1919 - Safeguarding America's Pharmaceuticals Act of 2013. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. S. 957 and S. 959 - The Drug Supply Chain of Security Act. Issues relating to generic drug labeling.
Safeguarding America's Pharmaceuticals Act of 2013
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
S. 1413: FDA User Fee Protection Act; H.R. 2725: FDA Safety Over Sequestration Act of 2013; PL 113-67: The Bipartisan Budget Act of 2013; H.R. 3547: 2014 Consolidated Appropriations Act PHA; PL113-54: Drug Quality and Security Act; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R.2725 FDA Safety Over Sequestration Act of 2013; S.1244 FY14 FDA Appropriations bill relating to sequestered user fees; S.1413 FDA User Fee Protection Act
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
H.R.3204 The Compounding Clarity Act; S.959 The Pharmaceutical Quality, Security and Accountability Act
Issues relating to generic drug labeling; S. 959: The Pharmaceutical Quality, Security and Accountability Act; H.R. 3204: The Compounding Clarity Act
H.R. 486 - relating to the compounding of drug products House Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding S. 959 Compounding and Pedigree bill
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
S.1244 - FY14 FDA Appropriations bill relating to sequestered user fees.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R.2725 FDA Safety Over Sequestration Act of 2013; S.1244 FY14 FDA Appropriations bill relating to sequestered user fees; S.1413 FDA User Fee Protection Act
H.R.2725 FDA Safety Over Sequestration Act of 2013; S.1244 FY14 FDA Appropriations bill relating to sequestered user fees; S.1413 FDA User Fee Protection Act
S. 1413: FDA User Fee Protection Act; H.R. 2725: FDA Safety Over Sequestration Act of 2013; PL 113-67: The Bipartisan Budget Act of 2013; H.R. 3547: 2014 Consolidated Appropriations Act PHA; PL113-54: Drug Quality and Security Act; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Issues relating to drug and nutrient shortages; P.L. 111-148: Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S. 232: Medical Device Access and Innovation Protection Act
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
HR. 1919 - Safeguarding America's Pharmaceuticals Act of 2013. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. S. 957 and S. 959 - The Drug Supply Chain of Security Act. Issues relating to generic drug labeling.
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
Pharmaceutical Quality, Security, and Accountability Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
Issues relating to generic drug labeling; S. 959: The Pharmaceutical Quality, Security and Accountability Act; H.R. 3204: The Compounding Clarity Act
Pharmaceutical Quality, Security, and Accountability Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR. 1919 - Safeguarding America's Pharmaceuticals Act of 2013. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. S. 957 and S. 959 - The Drug Supply Chain of Security Act. Issues relating to generic drug labeling.
Pharmaceutical Quality, Security, and Accountability Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R.3204 The Compounding Clarity Act; S.959 The Pharmaceutical Quality, Security and Accountability Act
Pharmaceutical Quality, Security, and Accountability Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R. 486 - relating to the compounding of drug products House Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding S. 959 Compounding and Pedigree bill
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R.933 Consolidated and Further Continuing Appropriations Act relating to FDA biosimilar user fees; S.Con. Res.8 - provisions relating to ACA medical device tax.
Preserving Access to Life-Saving Medications Act of 2011
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
AMP; Biosimilars; Drug Pedigree; S.3690 Drug Safety and Accountability Act; Drug Shortages; Generic Drug Labeling; Generic Drugs; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011; Safe Injection Practices; User Fees
Safeguarding America's Pharmaceuticals Act of 2011
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
Drug Shortages; Generic Drug Labeling; Generic Drugs; H.R.5651 Food and Drug Administration Reform Act of 2012; S.3187 Food and Drug Administration Safety and Innovation Act
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
H.R.8 American Taxpayer Relief Act of 2012 (Fiscal Cliff); Medical device tax delay
H.R.942 American Research and Competitiveness Act of 2011
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
AMP; Biosimilars; Drug Pedigree; S.3690 Drug Safety and Accountability Act; Drug Shortages; Generic Drug Labeling; Generic Drugs; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011; Safe Injection Practices; User Fees
Preserving Access to Life-Saving Medications Act of 2011
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
Antimicrobial Resistance and Healthcare; Drug Shortages; Safe Injection Practices; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.3690 Drug Safety and Accountability Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
Antimicrobial Resistance and Healthcare Acquired Infections H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
Antimicrobial Resistance and Healthcare Acquired Infections; Drug Shortages; Safe Injection Practices; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.3690 Drug Safety and Accountability Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011; 340B drug discount program; User Fees; Biosimilars
H.R.942 American Research and Competitiveness Act of 2011
H.R.942 American Research and Competitiveness Act of 2011
H.R.942 American Research and Competitiveness Act of 2011
H.R. 942 American Research and Competitiveness Act of 2011
Antimicrobial Resistance and Healthcare; Drug Shortages; Safe Injection Practices; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.3690 Drug Safety and Accountability Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011
Antimicrobial Resistance and Healthcare Acquired Infections; Drug Shortages; Safe Injection Practices; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.3690 Drug Safety and Accountability Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011; 340B drug discount program; User Fees; Biosimilars
To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit.
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 4213 American Jobs and Closing Tax Loopholes Act of 2010 HR 422 To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit
To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit.
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 422 To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit S 1203 Grow Research Opportunities With Taxcredits' Help Act; Growth Act
Medicare Home Infusion Therapy Coverage Act of 2009
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574/S 254 Medicare Home Infusion Therapy Coverage Act
HR 422 To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit S 1203 Grow Research Opportunities With Taxcredits' Help Act; Growth Act
HR 574/S 254 Medicare Home Infusion Therapy Coverage Act
Strengthening Program Integrity and Accountability in Health Care Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 3590 Patient Protection and Affordable Care Act HR 4872 Reconciliation Act of 2010 S 2964 Strengthening Program Integrity and Accountability in Health Care Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 2997/S 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 2997/S 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
HR 2997/S 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
HR 2997/S 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
American Middle Class Tax (AMT) Relief Act of 2007
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 3590 Patient Protection and Affordable Care Act HR 4872 Reconciliation Act of 2010
American Middle Class Tax (AMT) Relief Act of 2007
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 3590 Patient Protection and Affordable Care Act HR 4872 Reconciliation Act of 2010 S 2964 Strengthening Program Integrity and Accountability in Health Care Act
HR 1346 / S 540 Medical Device Safety Act of 2009; HR 1427 / S 726 The Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548, The Pathway to Biosimilars Act; HR 3590 Patient Protection and Affordability Act; S 1679 Affordable Health Choices Act; S 1796America's Healthy Future Act of 2009; Healthcare reform: device tax, Biosimilars pathway, medicare, patent reform
Promoting Innovation and Access to Life-Saving Medicine Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 1346 / S 540 Medical Device Safety Act of 2009; HR 1427 / S 726 The Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548, The Pathway to Biosimilars Act; HR 3590 Patient Protection and Affordability Act; S 1679 Affordable Health Choices Act; S 1796America's Healthy Future Act of 2009; Healthcare reform: device tax, Biosimilars pathway, medicare, patent reform
Promoting Innovation and Access to Life-Saving Medicine Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars Healthcare Reform bills in House and Senate (no Bill #s available)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars
Promoting Innovation and Access to Life-Saving Medicine Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574 / S254 Medicare Home Infusion Therapy Coverage Act of 2009; HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act; HR 1548 Pathway for Biosimilars; HR 3200 America's Affordable Health Choices Act of 2009; S 1679 Affordable Health Choices Act; Chairman's Mark, America's Health Future Act of 2009
HR 574 / S254 Medicare Home Infusion Therapy Coverage Act of 2009; HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act; HR 1548 Pathway for Biosimilars; HR 3200 America's Affordable Health Choices Act of 2009; S 1679 Affordable Health Choices Act; Chairman's Mark, America's Health Future Act of 2009
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars
HR 1346 / S 540 Medical Device Safety Act of 2009; HR 1427 / S 726 The Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548, The Pathway to Biosimilars Act; HR 3590 Patient Protection and Affordability Act; S 1679 Affordable Health Choices Act; S 1796America's Healthy Future Act of 2009; Healthcare reform: device tax, Biosimilars pathway, medicare, patent reform
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars Healthcare Reform bills in House and Senate (no Bill #s available)
HR 1788 False Claims Act Correction Act of 2009
HR 574 / S254 Medicare Home Infusion Therapy Coverage Act of 2009; HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act; HR 1548 Pathway for Biosimilars; HR 3200 America's Affordable Health Choices Act of 2009; S 1679 Affordable Health Choices Act; Chairman's Mark, America's Health Future Act of 2009
To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit.
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 422 To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit; S 1203 Grow Research Opportunities With Taxcredits' Help Act; Growth Act
Medicare Home Infusion Therapy Coverage Act of 2009
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars
Medicare Home Infusion Therapy Coverage Act of 2009
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574 / S254 Medicare Home Infusion Therapy Coverage Act of 2009; HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act; HR 1548 Pathway for Biosimilars; HR 3200 America's Affordable Health Choices Act of 2009; S 1679 Affordable Health Choices Act; Chairman's Mark, America's Health Future Act of 2009
Medicare Home Infusion Therapy Coverage Act of 2009
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars Healthcare Reform bills in House and Senate (no Bill #s available)
HR 422 To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit; S 1203 Grow Research Opportunities With Taxcredits' Help Act; Growth Act
HR 574 / S254 Medicare Home Infusion Therapy Coverage Act of 2009; HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act; HR 1548 Pathway for Biosimilars; HR 3200 America's Affordable Health Choices Act of 2009; S 1679 Affordable Health Choices Act; Chairman's Mark, America's Health Future Act of 2009
HR 1346 / S 540 Medical Device Safety Act of 2009; HR 1427 / S 726 The Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548, The Pathway to Biosimilars Act; HR 3590 Patient Protection and Affordability Act; S 1679 Affordable Health Choices Act; S 1796America's Healthy Future Act of 2009; Healthcare reform: device tax, Biosimilars pathway, medicare, patent reform
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars
HR 574 / S254 Medicare Home Infusion Therapy Coverage Act of 2009; HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act; HR 1548 Pathway for Biosimilars; HR 3200 America's Affordable Health Choices Act of 2009; S 1679 Affordable Health Choices Act; Chairman's Mark, America's Health Future Act of 2009
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars Healthcare Reform bills in House and Senate (no Bill #s available)
S 515 Patent Reform Act of 2009
S 515 Patent Reform Act of 2009
S 515 Patent Reform Act of 2009
HR 1346 / S 540 Medical Device Safety Act of 2009; HR 1427 / S 726 The Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548, The Pathway to Biosimilars Act; HR 3590 Patient Protection and Affordability Act; S 1679 Affordable Health Choices Act; S 1796America's Healthy Future Act of 2009; Healthcare reform: device tax, Biosimilars pathway, medicare, patent reform
Promoting Innovation and Access to Life-Saving Medicine Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574 / S254 Medicare Home Infusion Therapy Coverage Act of 2009; HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act; HR 1548 Pathway for Biosimilars; HR 3200 America's Affordable Health Choices Act of 2009; S 1679 Affordable Health Choices Act; Chairman's Mark, America's Health Future Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars Healthcare Reform bills in House and Senate (no Bill #s available)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 1346 / S 540 Medical Device Safety Act of 2009; HR 1427 / S 726 The Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548, The Pathway to Biosimilars Act; HR 3590 Patient Protection and Affordability Act; S 1679 Affordable Health Choices Act; S 1796America's Healthy Future Act of 2009; Healthcare reform: device tax, Biosimilars pathway, medicare, patent reform
Promoting Innovation and Access to Life-Saving Medicine Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars
American Middle Class Tax (AMT) Relief Act of 2007
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 1346 / S 540 Medical Device Safety Act of 2009; HR 1427 / S 726 The Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548, The Pathway to Biosimilars Act; HR 3590 Patient Protection and Affordability Act; S 1679 Affordable Health Choices Act; S 1796America's Healthy Future Act of 2009; Healthcare reform: device tax, Biosimilars pathway, medicare, patent reform
HR 1038 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 HR 5629 Pathway for Biosimilars Act
HR1038 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 HR 5629 Pathway for Biosimilars Act
HR 1038 / S 623 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act HR 5629 The Pathway for Biosimilars Act
S 1145 / HR 1908: Patent Reform Act of 2007
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR1038 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 HR 5629 Pathway for Biosimilars Act
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 1038 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 HR 5629 Pathway for Biosimilars Act
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR 1038 / S 623 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act HR 5629 The Pathway for Biosimilars Act
HR 3610 Food and Drug Import Safety Act of 2007 HR 5839 Safeguarding America's Pharmaceutical Act of 2008 S 3409 Drug and Device Accountability Act of 2008
HR 3610 Food and Drug Import Safety Act of 2007 HR 5839 Safeguarding America's Pharmaceutical Act of 2008 S 3409 Drug and Device Accountability Act of 2008
HR 3610 The Food and Drug Import Safety Bill JR 5839 Safeguarding America's Pharmaceutical Act of 2008
HR 5629: Pathway for Biosimilars Act
HR1038 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 HR 5629 Pathway for Biosimilars Act
HR 1038 / S 623 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act HR 5629 The Pathway for Biosimilars Act
Issues relating to medical product cybersecurity
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · 2A
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Issues relating to medical product cybersecurity
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · 1A
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
Working to ensure that issues related to coding and reimbursement are discussed and addressed to ensure a smooth start to the coverage of biosimilar medications as they enter into the United States' prescription drug market this year.
Issues related to the naming of biosimilars as they enter into the national prescription drug marketplace; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2015 · third_quarter · 3T
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Issues relating to medical product cybersecurity
Implementation of the Biologics Price Competition and Innovation Act (BPCIA); CMS Proposed Rule {CMS-1631-P} RIN 0938-AS40 - Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Q2
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
Issues relating to medical product cybersecurity
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Q1
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
Issues related to the naming of biosimilars as they enter into the national prescription drug marketplace; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Working to ensure that issues related to coding and reimbursement are discussed and addressed to ensure a smooth start to the coverage of biosimilar medications as they enter into the United States' prescription drug market this year.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · fourth_quarter · Q4
Issues related to integrating biosimilar medications into the Medicare and Medicaid programs; issues related to creating a new marketplace for biosimilar medications in the United States.
Issues relating to opioid abuse and drug shortages; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Q3
Issues relating to drug shortages; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94).
Implementation of the Biologics Price Competition and Innovation Act (BPCIA) relating to biosimilar naming and reimbursement; issues related to drug approvals at the FDA including biosimilars.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2014 · second_quarter · Q2
Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products).
Implementation of the Biologics Price Competition and Innovation Act (BPCIA) relating to biosimilar naming. Issues relating to opiate overdosing. Issues related to drug approvals at the FDA including biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2014 · first_quarter · Q1
Issues relating to drug shortages, patent use codes and drug labeling (RIN:0910-AG94: FDA Proposed Rule on Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products).
The Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act relating to delay of the ACA medical device tax.
Issues related to drug approvals at the FDA including biosimilars; issues related to drug shortages; issues related to heroin and opioid overdose.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2013 · fourth_quarter · Q4
Issues relating to drug and nutrient shortages; P.L. 111-148: Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S. 232: Medical Device Access and Innovation Protection Act
S. 1413: FDA User Fee Protection Act; H.R. 2725: FDA Safety Over Sequestration Act of 2013; PL 113-67: The Bipartisan Budget Act of 2013; H.R. 3547: 2014 Consolidated Appropriations Act PHA; PL113-54: Drug Quality and Security Act; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
Issues relating to generic drug labeling; S. 959: The Pharmaceutical Quality, Security and Accountability Act; H.R. 3204: The Compounding Clarity Act
2013 · third_quarter · Q3
H.R.2725 FDA Safety Over Sequestration Act of 2013; S.1244 FY14 FDA Appropriations bill relating to sequestered user fees; S.1413 FDA User Fee Protection Act
H.R.3204 The Compounding Clarity Act; S.959 The Pharmaceutical Quality, Security and Accountability Act
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
2013 · second_quarter · Q2
HR. 1919 - Safeguarding America's Pharmaceuticals Act of 2013. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. S. 957 and S. 959 - The Drug Supply Chain of Security Act. Issues relating to generic drug labeling.
S.1244 - FY14 FDA Appropriations bill relating to sequestered user fees.
H.R. 486 - relating to the compounding of drug products House Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding S. 959 Compounding and Pedigree bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Q1
PL 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. Issues relateing to generic drug labeling and drug pedigree.
H.R.933 Consolidated and Further Continuing Appropriations Act relating to FDA biosimilar user fees; S.Con. Res.8 - provisions relating to ACA medical device tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Q4
S.2295 Patient Safety and Generic Labeling Improvement Act; Senate Draft Proposal to Improve Drug Distribution Security
IP
H.R.8 American Taxpayer Relief Act of 2012 (Fiscal Cliff); Medical device tax delay
2012 · third_quarter · Q3
IP
Trade
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Q2
Drug Shortages; Generic Drug Labeling; Generic Drugs; H.R.5651 Food and Drug Administration Reform Act of 2012; S.3187 Food and Drug Administration Safety and Innovation Act
Trade
IP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2012 · first_quarter · Q1
AMP; Biosimilars; Drug Pedigree; S.3690 Drug Safety and Accountability Act; Drug Shortages; Generic Drug Labeling; Generic Drugs; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011; Safe Injection Practices; User Fees
H.R.942 American Research and Competitiveness Act of 2011
IP
2011 · fourth_quarter · Q4
H.R.942 American Research and Competitiveness Act of 2011
Antimicrobial Resistance and Healthcare Acquired Infections; Drug Shortages; Safe Injection Practices; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.3690 Drug Safety and Accountability Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011; 340B drug discount program; User Fees; Biosimilars
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · third_quarter · Q3
S.Amdt.633 -- To provide trade promotion authority for the Trans-Pacific Partnership Agreement and for other trade agreements
H.R.942 American Research and Competitiveness Act of 2011
Antimicrobial Resistance and Healthcare; Drug Shortages; Safe Injection Practices; H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act; S.3690 Drug Safety and Accountability Act; S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · second_quarter · Q2
Antimicrobial Resistance and Healthcare Acquired Infections H.R.2245 / S.296 Preserving Access to Life-Saving Medications Act S.454 Strengthening Program Integrity and Accountability in Health Care Act of 2011
H.R.942 American Research and Competitiveness Act of 2011
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · first_quarter · Q1
H.R. 942 American Research and Competitiveness Act of 2011
S. 296 Preserving Access to Life-Saving Medications Act Antimicrobial Resistance and Healthcare Acquired Infections Medical Device Tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Q4
HR 2997/S 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
HR 4213 American Jobs and Closing Tax Loopholes Act of 2010
Generic drug user fees; HIT, Meaningful use; small bore connector issue
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Q3
Small bore connector issue HIT, meaningful use (ONCHIT)
HR 2997/S 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
HR 4213 American Jobs and Closing Tax Loopholes Act of 2010
2010 · second_quarter · Q2
HR 3590 Patient Protection and Affordable Care Act HR 4872 Reconciliation Act of 2010 S 2964 Strengthening Program Integrity and Accountability in Health Care Act
HR 4213 American Jobs and Closing Tax Loopholes Act of 2010 HR 422 To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Q1
HR 422 To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit S 1203 Grow Research Opportunities With Taxcredits' Help Act; Growth Act
HR 3590 Patient Protection and Affordable Care Act HR 4872 Reconciliation Act of 2010
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Q4
HR 2847 FY 2010 Commerce Justice State Appriations Act relating to PTO acceptance of late filings
HR 1346 / S 540 Medical Device Safety Act of 2009; HR 1427 / S 726 The Promoting Innovation and Access to Life-Saving Medicine Act; HR 1548, The Pathway to Biosimilars Act; HR 3590 Patient Protection and Affordability Act; S 1679 Affordable Health Choices Act; S 1796America's Healthy Future Act of 2009; Healthcare reform: device tax, Biosimilars pathway, medicare, patent reform
HR 1788 False Claims Act Correction Act of 2009
2009 · third_quarter · Q3
HR 574 / S254 Medicare Home Infusion Therapy Coverage Act of 2009; HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act; HR 1548 Pathway for Biosimilars; HR 3200 America's Affordable Health Choices Act of 2009; S 1679 Affordable Health Choices Act; Chairman's Mark, America's Health Future Act of 2009
Medical Device Tax (no bill # available)
S 515 Patent Reform Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Q2
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars Healthcare Reform bills in House and Senate (no Bill #s available)
S 515 Patent Reform Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Q1
Senate and House Budget Resolutions
HR 574 / S 254 Medicare Home Infusion Therapy Coverage Act of 2009 HR 1427 / S 726 Promoting Innovation and Access to Life Saving Medicines Act HR 1548 Pathway for Biosimilars
S 515 Patent Reform Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Q4
HR 1424 The Emergency Economic Stabilization Act of 2008 HR 6409 R & D Tax Credit Extender S 3125 Energy Independence and Tax Relief Act of 2008
HR 3610 Food and Drug Import Safety Act of 2007 HR 5839 Safeguarding America's Pharmaceutical Act of 2008 S 3409 Drug and Device Accountability Act of 2008
HR 1038 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 HR 5629 Pathway for Biosimilars Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Q3
HR 3610 Food and Drug Import Safety Act of 2007 HR 5839 Safeguarding America's Pharmaceutical Act of 2008 S 3409 Drug and Device Accountability Act of 2008
HR1038 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 HR 5629 Pathway for Biosimilars Act
HR 1424 The Emergency Economic Stabilization Act of 2008 HR 6409 R & D Tax Credit Extender S 3125 Energy Independence and Tax Relief Act of 2008
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Q2
S. 3125 R& D Tax Extender
HR 1038 / S 623 Access to Life-Saving Medicine Act HR 1956 Patient Protection and Innovative Biologic Medicines Act HR 5629 The Pathway for Biosimilars Act
HR 3610 The Food and Drug Import Safety Bill JR 5839 Safeguarding America's Pharmaceutical Act of 2008
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Q1
S 1145 / HR 1908: Patent Reform Act of 2007
HR 5629: Pathway for Biosimilars Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · RA
Biogenerics, Medicare, Medicaid, Patent Reform, Prescription Drugs, Medical Devices
Biogenerics, Medicare, Medicaid, Patent Reform, Prescription Drugs, Medical Devices
Biogenerics, Medicare, Medicaid, Patent Reform, Prescription Drugs, Medical Devices
2007 · year_end · YY
PL-110-85, Food and Drug Administration Revitalization Act of 2007
S 1693: Wired for Health Care Quality Act HR 3610: Food and Drug Import Safety Act of 2007 S 1695: Biologics Price Competition and Innovation Act of 2007 HR 1038: Access to LIfe Saving Medicines Act
S 2221: Transparency in Medical Device Pricing Act of 2007 S 2029: Physician Payment Sunshine Act Hr 3700 S 1951: Fair Medicaid Drug Payment Act
2007 · mid_year · MM
HR 1038 / S 623: "Access to Life Saving Medicines Act", Support Biogenerics. In the Senate: "The Biologics Price Competition and Innovation Act of 2007", Supports Biogenerics. S 1082: "The FDA Revitalization Act of 2007", Reauthorizes prescription drug and medical device user fee legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · MM
HR 1038 / S 623: "Access to Life Saving Medicines Act", Support Biogenerics. In the Senate: "The Biologics Price Competition and Innovation Act of 2007", Supports Biogenerics. S 1082: "The FDA Revitalization Act of 2007", Reauthorizes prescription drug and medical device user fee legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · RR
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Trade
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Trade
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
HR 574/S 254 Medicare Home Infusion Therapy Coverage Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 422 To amend the Internal Revenue Code of 1986 to extend the research credit through 2010 and to increase and make permanent the alternative simplified research credit; S 1203 Grow Research Opportunities With Taxcredits' Help Act; Growth Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Biogenerics, Medicare, Medicaid, Patent Reform, Prescription Drugs, Medical Devices
Biogenerics, Medicare, Medicaid, Patent Reform, Prescription Drugs, Medical Devices
S1145 / HR 1908: Patent Reform Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE